These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26265385)

  • 1. Future therapy for hepatitis B virus infection.
    Minami M
    Clin J Gastroenterol; 2015 Aug; 8(4):167-71. PubMed ID: 26265385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection.
    Wang Z; Kawaguchi K; Honda M; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):682-687. PubMed ID: 29752943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent Advances in Hepatitis B Virus Antivirals].
    Liu Q; Yao C; Guo X; Hu K
    Bing Du Xue Bao; 2016 Sep; 32(5):650-8. PubMed ID: 30004193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside analogs as anti-HBV agents.
    Zhou XX; Littler E
    Curr Top Med Chem; 2006; 6(9):851-65. PubMed ID: 16787280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
    Zoulim F
    Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B.
    Shi M; Sun WL; Hua YY; Han B; Shi L
    PLoS One; 2015; 10(2):e0117741. PubMed ID: 25647607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-hepatitis B virus drugs].
    Minami M
    Nihon Rinsho; 2012 Apr; 70(4):609-13. PubMed ID: 22568141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
    Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
    Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cccDNA function in hepatitis B virus infection.
    Levrero M; Pollicino T; Petersen J; Belloni L; Raimondo G; Dandri M
    J Hepatol; 2009 Sep; 51(3):581-92. PubMed ID: 19616338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of interferon and nucleoside analogues.
    Thomas H; Foster G; Platis D
    J Hepatol; 2003; 39 Suppl 1():S93-8. PubMed ID: 14708685
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
    Brown A; Goodman Z
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro models for studying hepatitis B virus drug resistance.
    Zoulim F
    Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical cure strategies for hepatitis B: direct-acting antiviral drugs].
    Huang AL; Yuan ZH; Nan YM; Yang DL; Guo JT; Li WH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):640-644. PubMed ID: 32911899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interferon-based versus direct antiviral therapy in patients with chronic hepatitis B].
    Tornai I
    Orv Hetil; 2011 May; 152(22):869-74. PubMed ID: 21565754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics.
    Pawlotsky JM
    J Hepatol; 2003; 39 Suppl 1():S31-5. PubMed ID: 14708675
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial overview: Antiviral strategies: Virological and immunological basis for HBV cure.
    Urban S; Bertoletti A
    Curr Opin Virol; 2018 Jun; 30():iv-vi. PubMed ID: 29866361
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B: a "GLOBAL" health challenge.
    Fontana RJ
    Gastroenterology; 2009 Feb; 136(2):389-92. PubMed ID: 19109963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.